DOCU$68.22

DocuSign shows improving operating performance, with revenue rising from $2.11B to $3.22B over FY2022-FY2026 and TTM revenue of $3.29B slightly ahead of FY2026, indicating modest re-acceleration. Gross margin has stayed remarkably stable near 79.5%, while operating margin expanded from negative to 10.64%, showing better operating leverage. However, net income is not fully durable: FY2025 net income spiked to $1.07B largely because of a roughly $820M tax benefit, then normalized to $309M TTM, so bottom-line growth is less reliable than operating trends suggest. Free cash flow remains strong at $1.12B with a 34.09% margin, but R&D and SG&A remain sizeable and warrant monitoring.

DocuSign’s balance sheet is moderately solid but not especially liquid. Current assets of $1.26B are below current liabilities of $1.89B, leaving working capital at -$633M; however, the shortfall is largely driven by deferred revenue rather than heavy near-term debt. Cash and short-term investments remain healthy at $814M, and total debt is modest at $183M, so solvency pressure appears limited. Total assets of $3.98B exceed total liabilities of $2.16B, and shareholders’ equity remains positive at $1.82B. Equity has grown over time, but the retained earnings balance is deeply negative at -$2.10B, reflecting accumulated losses. Overall, the structure is manageable, though liquidity remains tight.

DocuSign shows solid cash generation, with operating cash flow rising from $506M in FY2022 to $1.17B in FY2026 and reaching $1.24B TTM. Free cash flow is also strong and improving, at $1.06B TTM after $115M of capital expenditures, suggesting reinvestment remains controlled relative to operating cash generation. FCF margin expanded to 34.09%, which is healthy for a software business. The main caution is quality: working capital has been a persistent cash drag, and FY2025 included a sharp negative swing in other operating activities. Capital allocation is shareholder-focused, with heavy buybacks of $1.14B in FY2026 and $1.25B TTM, while debt reduction has not been a recent theme. Overall, cash production is good, though not perfectly smooth.

DocuSign shows a mixed operating profile. Liquidity has weakened over time: the current ratio fell from 0.96 to 0.67 and the quick ratio from 0.92 to 0.60, suggesting less cushion for near-term obligations, though cash generation still helps. Leverage has improved markedly versus FY2022, with debt-to-equity dropping from 3.2 to about 0.1 and debt-to-EBITDA down to 0.44, indicating a much more manageable balance sheet. Efficiency is broadly stable but not strong, with asset turnover hovering around 0.8–0.9. Profitability improved sharply after FY2023, with ROE, ROA, ROIC, and ROCE all positive and healthier than earlier years, but returns have softened from their FY2025 peaks.

DocuSign’s revenue path shows a clear slowdown from the early 20% growth pace to high-single-digit expansion, then a steadier forward profile with a modest reacceleration to the mid-to-high 8% range. That suggests a move from rapid expansion toward more mature, compounding growth rather than a sharp inflection. EPS has been far more volatile than revenue, with a strong historical rebound and then uneven but improving forecast growth, indicating earnings are still sensitive to margin mix and expense discipline. Analyst sentiment is cautious overall: the consensus is Hold, the target range is wide, and coverage from 21 analysts gives the view reasonable confidence. The recommendation mix has been broadly stable, with only a slight tilt away from Buy over recent months.